Biohaven (NYSE:BHVN) Given “Buy” Rating at HC Wainwright
HC Wainwright reissued their buy rating on shares of Biohaven (NYSE:BHVN – Free Report) in a report issued on Tuesday,Benzinga reports. The firm currently has a $54.00 price target on the stock. Several other equities analysts also recently commented on BHVN. Cantor Fitzgerald reiterated an “overweight” rating on shares of Biohaven in a report on […]
